Search Options Stock News and Analysis from Schaeffer's

Fed Rate Cut, Big Tech Slide Highlight Volatile Week

https://www.schaeffersresearch.com/content/news/2025/12/12/fed-rate-cut-big-tech-slide-highlight-volatile-week

12/12/2025 2:07 PM

The beginning of the week saw fairly muted trading, as investors awaited Wednesday's highly anticipated interest rate decision. The central bank cut rates by 25 basis points for the third -- and f...

2 Pharma Stocks Pop on Strong Obesity Drug Trial Results

https://www.schaeffersresearch.com/content/news/2025/12/11/2-pharma-stocks-pop-on-strong-obesity-drug-trial-results

12/11/2025 11:16 AM

Positive drug trial results are boosting pharmaceutical stocks today, with Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) and Eli Lilly & Co. (NYSE:LLY) drawing investor attention after encourag...

Tech Rebound, Economic Data Fuel Weekly Gains

https://www.schaeffersresearch.com/content/news/2025/12/05/tech-rebound-economic-data-fuel-weekly-gains

12/5/2025 2:41 PM

Wall Street saw more tech-fueled volatility in the first couple days of December, with stocks falling sharply on Monday before bouncing back on Tuesday -- in part due to Bitcoin's (BTC) selloff and ...

Eli Lilly Stock in Focus After Slashing Cost of Popular Drug

https://www.schaeffersresearch.com/content/news/2025/12/01/eli-lilly-stock-in-focus-after-slashing-cost-of-popular-drug

12/1/2025 10:56 AM

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The single-d...

The Week Ahead: Tech Earnings, Interest Rate Decision

https://www.schaeffersresearch.com/content/news/2025/10/23/the-week-ahead-tech-earnings-interest-rate-decision

10/23/2025 1:01 PM

Plenty of key economic indicators are due out next week, but it's unclear whether or not investors will be able to sift through them due to the government shutdown, which is now on its fourth week. Du...

PEOPLE ALSO SEARCH FOR